PL4077639T3 - Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi - Google Patents

Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi

Info

Publication number
PL4077639T3
PL4077639T3 PL20833822.8T PL20833822T PL4077639T3 PL 4077639 T3 PL4077639 T3 PL 4077639T3 PL 20833822 T PL20833822 T PL 20833822T PL 4077639 T3 PL4077639 T3 PL 4077639T3
Authority
PL
Poland
Prior art keywords
immunoregulator
blood
cells
producing
derived sample
Prior art date
Application number
PL20833822.8T
Other languages
English (en)
Inventor
Robert ZEISER
Petya Apostolova
Justus Duyster
Original Assignee
Mallinckrodt Pharmaceuticals Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Pharmaceuticals Ireland Limited filed Critical Mallinckrodt Pharmaceuticals Ireland Limited
Publication of PL4077639T3 publication Critical patent/PL4077639T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
    • C12N2529/10—Stimulation by light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL20833822.8T 2019-12-20 2020-12-17 Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi PL4077639T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19218724 2019-12-20
PCT/EP2020/086733 WO2021122969A1 (en) 2019-12-20 2020-12-17 Method for generating immunoregulatory cells in a blood-derived sample

Publications (1)

Publication Number Publication Date
PL4077639T3 true PL4077639T3 (pl) 2024-09-30

Family

ID=69005255

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20833822.8T PL4077639T3 (pl) 2019-12-20 2020-12-17 Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi

Country Status (15)

Country Link
EP (2) EP4077639B1 (pl)
JP (2) JP7701925B2 (pl)
KR (1) KR20220118404A (pl)
CN (1) CN114901809A (pl)
AU (1) AU2020404121A1 (pl)
BR (1) BR112022010129A2 (pl)
CA (1) CA3164882A1 (pl)
DK (1) DK4077639T3 (pl)
ES (1) ES2985816T3 (pl)
FI (1) FI4077639T3 (pl)
IL (1) IL293773A (pl)
MX (1) MX2022006381A (pl)
PL (1) PL4077639T3 (pl)
PT (1) PT4077639T (pl)
WO (1) WO2021122969A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115735846B (zh) * 2022-11-29 2025-09-16 复旦大学附属华山医院 磁场联合光化学诱导无创性缺血性脑卒中模型的建立方法
CN120641093A (zh) * 2022-12-21 2025-09-12 马林克罗特制药爱尔兰有限公司 脂联素单独或与体外光分离置换(ecp)组合用于治疗免疫检查点抑制剂的免疫相关不良事件
EP4389122A1 (en) * 2022-12-21 2024-06-26 Mallinckrodt Pharmaceuticals Ireland Limited Adiponectin alone or in combination with extracorporeal photopheresis (ecp) for immune related adverse events of immune checkpoint inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5984887A (en) 1996-03-29 1999-11-16 Therakos, Inc. Photopheresis treatment of leukocytes
PT994743E (pt) * 1997-07-10 2006-08-31 Therakos Inc Tratamento de disturbios inflamatorios do intestino ou da bexiga
TWI324068B (en) * 2003-03-13 2010-05-01 Kirin Holdings Kk Antiallergic composition
EP1951036A4 (en) * 2005-11-02 2009-05-27 Therakos Inc USE OF APIVOTIC CELLS EX VIVO FOR GENERATING REGULATORY T CELLS
CN108578675A (zh) * 2018-03-13 2018-09-28 中国农业大学 一种小鼠嗜酸性粒细胞食管炎食物过敏模型的建立方法

Also Published As

Publication number Publication date
CN114901809A (zh) 2022-08-12
JP7701925B2 (ja) 2025-07-02
CA3164882A1 (en) 2021-06-24
DK4077639T3 (da) 2024-08-19
JP2023506413A (ja) 2023-02-16
EP4077639B1 (en) 2024-06-12
EP4374876A2 (en) 2024-05-29
PT4077639T (pt) 2024-09-10
JP2025126235A (ja) 2025-08-28
IL293773A (en) 2022-08-01
EP4374876A3 (en) 2024-08-07
ES2985816T3 (es) 2024-11-07
WO2021122969A1 (en) 2021-06-24
BR112022010129A2 (pt) 2022-08-09
KR20220118404A (ko) 2022-08-25
MX2022006381A (es) 2022-06-24
US20230024405A1 (en) 2023-01-26
FI4077639T3 (fi) 2024-08-22
EP4077639A1 (en) 2022-10-26
AU2020404121A1 (en) 2022-06-23

Similar Documents

Publication Publication Date Title
EP3758719A4 (en) METHODS FOR IMPROVING THE DIFFERENTIATION OF STEM CELLS INTO BETA CELLS
TWI799601B (zh) Lgps系固體電解質及其製造方法
IL287468A (en) Nucleic acid constructs and methods for their manufacture
PL3855561T3 (pl) Sposób wytwarzania ogniwa elektrycznego z masą zalewową
EP3863100A4 (en) METHOD OF MANUFACTURE OF A LITHIUM ION CELL AND LITHIUM ION CELL
KR102204140B9 (ko) 전고체 전지 및 이의 제조방법
EP2970890A4 (en) COMPOSITIONS AND METHOD FOR THE REPRODUCTION AND BREEDING OF EPITHELIC STEM CELLS
PL4077639T3 (pl) Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi
PL3443609T3 (pl) Sposoby produkcyjne o dużej przepustowości do wytwarzania elektrochemicznych ogniw elementarnych oraz elektrochemiczne ogniwa elementarne wytwarzane przy ich zastosowaniu
EP3633687C0 (en) ELECTROLYTE FOR ELECTROCHEMICAL DEVICE AND PREPARATION METHOD THEREOF
SG11201706090SA (en) Cell culturing method and kit
PL3835415T3 (pl) Sposób wytwarzania komórki cd3-dodatniej
EP3591040A4 (en) METHOD OF PRODUCTION OF PANCREATIC PROGENITOR CELLS
EP4022041A4 (en) NEF-CONTAINING T CELLS AND METHODS OF PRODUCTION THEREOF
IL304401A (en) Blastocyst-like cell aggregate and methods
EP4167343C0 (en) METHOD FOR IMPROVING THE PERFORMANCE OF AN ELECTROCHEMICAL CELL
EP3515862A4 (en) ELECTROCHEMICAL CELLS AND METHOD FOR THE PRODUCTION THEREOF
EP3950711A4 (en) CELL CONSTRUCT AND METHODS OF PRODUCTION
FR3053051B1 (fr) Cassette et automate de culture cellulaire
EP4016568A4 (en) SEPARATOR FOR BATTERIES AND ITS PRODUCTION METHOD
SI3997741T1 (sl) Struktura sončne celice z zadnjim emitorjem s heterospojem ter postopek in naprava za izdelavo le-te
EP4029949A4 (en) KIT AND PROCESS
IL284893A (en) A method for screening of an in vitro display library within a cell
EP4289941A4 (en) METHOD OF REPROGRAMMING A CELL
HUE065442T2 (hu) Eljárás tasak-alakú akkumulátorcella elõállítására sablon egyengetéssel